Type 2 diabetes is a long-term condition where the body struggles to manage sugar levels in the blood. Normally, doctors ...

The Bronx is also home to the four neighborhoods with the highest blood-sugar levels in the city among people who are ...

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...

Jim Cramer continues to praise Abbott Laboratories, dubbing it a “tour de force” despite market tremors caused by a Chinese ...

Diabetic macular edema is a complication that develops from diabetic retinopathy, a widespread consequence of diabetes and a ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

Despite decades of research establishing the safety and efficacy of cholesterol-lowering medications, adherence remains a ...

Novo Nordisk NVO is expected to beat estimates when it reports its first-quarter 2025 results before the opening bell on May ...

Advances in type 1 diabetes technology give people with the condition and their caregivers a little more freedom in their ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...